+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Prognostic value of a systemic inflammatory response index in metastatic renal cell carcinoma and construction of a predictive model



Prognostic value of a systemic inflammatory response index in metastatic renal cell carcinoma and construction of a predictive model



Oncotarget: -




(PDF emailed within 1 workday: $29.90)

Accession: 058637599

Download citation: RISBibTeXText

PMID: 27447974


Related references

External validation of the systemic immune-inflammation index as a prognostic factor in metastatic renal cell carcinoma and its implementation within the international metastatic renal cell carcinoma database consortium model. International Journal of Clinical Oncology 2019, 2019

Prognostic significance of the dynamic changes of systemic inflammatory response in metastatic renal cell carcinoma. International Braz J Urol 45(1): 89-99, 2018

Prognostic nutritional index serves as a predictive marker of survival and associates with systemic inflammatory response in metastatic intrahepatic cholangiocarcinoma. Oncotargets and Therapy 9: 6417-6423, 2016

The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study. Lancet. Oncology 16(3): 293-300, 2015

Prognostic role of systemic inflammatory response in renal cell carcinoma: a systematic review and meta-analysis. Journal of Cancer Research and Clinical Oncology 137(5): 887-896, 2011

Comparison of the prognostic value of pretreatment measurements of systemic inflammatory response in patients undergoing curative resection of clear cell renal cell carcinoma. World Journal of Urology 33(12): 2045-2052, 2016

The predictive value of a preoperative systemic immune-inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma. Journal of Cellular Physiology 234(2): 1794-1802, 2018

Validation of the International Metastatic Renal-Cell Carcinoma Database Consortium (IMDC) prognostic model for first-line pazopanib in metastatic renal carcinoma: the Spanish Oncologic Genitourinary Group (SOGUG) SPAZO study. Annals of Oncology 27(4): 706-711, 2016

Prognostic and predictive markers in metastatic renal cell carcinoma. Journal of Clinical Oncology 31(7): 971-972, 2013

Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model. Journal of Translational Medicine 13: 66, 2016

Prognostic and predictive factors of immunotherapy in metastatic renal cell carcinoma. Critical Reviews in Oncology/Hematology 41(3): 327-334, 2002

The Impact of PBRM1 Expression as a Prognostic and Predictive Marker in Metastatic Renal Cell Carcinoma. Journal of Urology 194(4): 1112-1119, 2015

Predictive and prognostic effect of inflammatory lymphadenopathies in renal cell carcinoma. World Journal of Urology 2018, 2018

Glycoprotein non-metastatic melanoma protein B as a predictive prognostic factor in clear-cell renal cell carcinoma following radical nephrectomy. Molecular Medicine Reports 9(3): 851-856, 2014

Significance of preoperative prognostic nutrition index as prognostic predictors in patients with metastatic renal cell carcinoma with tyrosine kinase inhibitors as first-line target therapy. International Urology and Nephrology 49(11): 1955-1963, 2017